Biologics for the Treatment of Rheumatoid Arthritis (PDF)

Professor Ronald F van Vollenhoven is Chief of the Unit for Clinical Therapy Research,
Inflammatory Diseases (ClinTRID) at the Karolinska Institute, and of the
Clinical Trials Unit Rheumatology at the Karolinska University Hospital. He
received his MD and PhD degrees from the University of Leiden in The
Netherlands. After graduating in 1984 he pursued
immunology research at Cornell Medical College in New York, followed by a
residency (specialty training) in internal medicine at the State University of
New York at Stony Brook, and a fellowship in rheumatology at Stanford
University in Palo Alto following which he received American Board of Internal
Medicine certification in both internal medicine and rheumatology. From 1993 to
1998 Professor van Vollenhoven held a faculty appointment as Assistant
Professor of Medicine in the Division of Immunology and Rheumatology at
Stanford University, and from 1995 he was the Medical Services Chief and
Fellowship Director in that division. In 1998 Professor van Vollenhoven moved
to Stockholm, Sweden, where he worked as a Senior Physician and Chief of the
Clinical Trials Unit in the Department of Rheumatology at the Karolinska
University Hospital and Associate Professor of Rheumatology; and in 2010, he
was appointed in his current position as Professor and Unit Chief at the
Karolinska Institute.


Professor
van Vollenhoven's research interests focus around the development and
systematic evaluation of biologic and immunomodulatory treatments for the
rheumatic diseases. With his co-workers, he has established the Stockholm
registry for biological therapies (the STURE database) for this purpose, which
has supported research projects relating to clinical efficacy, pharmacology,
outcomes, and pharmacoeconomics. He has been principal investigator in many
clinical trials of novel therapies in rheumatic diseases and has contributed to
a number of important investigator-initiated trials including the